These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2303802)

  • 21. Relative functional affinity of specific anti-core IgG in different categories of hepatitis B virus infection.
    Thomas HI
    J Med Virol; 1997 Mar; 51(3):189-97. PubMed ID: 9139082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B virus e antigen specific epitopes and limitations of commercial anti-HBe immunoassays.
    Baumeister MA; Medina-Selby A; Coit D; Nguyen S; George-Nascimento C; Gyenes A; Valenzuela P; Kuo G; Chien DY
    J Med Virol; 2000 Mar; 60(3):256-63. PubMed ID: 10630956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Virological, serological and clinical characteristics of anti-HBc IgM positive chronic hepatitis B patients].
    Zhang CZ; Tian ZX; Shi SZ; Li MH; Xie Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):138-40. PubMed ID: 17653316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [IgM anti-HBc in the differential diagnosis of co- and HDV superinfection].
    Fedorchenko SV; Vozianova SV
    Ter Arkh; 1991; 63(11):55-8. PubMed ID: 1810065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-Reactivity of HBe Antigen-Specific Polyclonal Antibody with HBc Antigen.
    Hojatizadeh M; Amiri MM; Mobini M; Hassanzadeh Makoui M; Ghaedi M; Ghotloo S; Peyghami K; Jeddi-Tehrani M; Golsaz-Shirazi F; Shokri F
    Viral Immunol; 2023; 36(6):378-388. PubMed ID: 37294935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilizing self-prepared ELISA plates for a cross-population study of different anti-HBe IgG subclass profiles.
    Wang L; Tsai TH; Huang CF; Ho MS; Lin DB; Ho YC; Lin SS; Wei JC; Chou MC; Yang CC
    J Med Virol; 2007 May; 79(5):495-502. PubMed ID: 17385671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mixed cryoglobulinemia type II in chronic hepatitis B associated with HBe-minus HBV mutant: cellular immune reactions and response to interferon treatment.
    Löhr H; Goergen B; Weber W; Gödderz W; Meyer zum Büschenfelde KH; Gerken G
    J Med Virol; 1994 Dec; 44(4):330-5. PubMed ID: 7897364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic T-cell responses to the nucleocapsid proteins of HBV in chronic hepatitis. Evidence that antibody modulation may cause protracted infection.
    Pignatelli M; Waters J; Lever A; Iwarson S; Gerety R; Thomas HC
    J Hepatol; 1987 Feb; 4(1):15-21. PubMed ID: 3494760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-HBc of IgM-class, HBeAg and anti-HBe in acute and chronic hepatitis B.
    Aldershvile J; Roggendorf M; Kryger P; Tage-Jensen U; Deinhardt F; Frösner GG; Hardt F; Nielsen JO
    Liver; 1981 Dec; 1(4):290-7. PubMed ID: 7348762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follow-up studies on IgM anti-HBc during chronic hepatitis B.
    Lindenschmidt EG
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Jul; 261(4):461-70. PubMed ID: 3765952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of antibody to hepatitis Be antigen (anti-HBe) in HBsAg-negative individuals.
    Hess G; Arnold W; Gahl GM; Vogl E; Meyer zum Büschenfelde KH
    Vox Sang; 1981 Feb; 40(2):95-8. PubMed ID: 7233888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulin M antibody to hepatitis B core antigen (IgM anti-HBc) as a marker of interferon therapy in patients with persistent hepatitis B virus infection.
    Nakajima E; Tsuji T; Kachi K; Kagawa K; Okanoue T; Takino T; Yamada A; Imanishi J
    Biken J; 1987 Mar; 30(1):17-23. PubMed ID: 3675547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suitability of yeast- and Escherichia coli-expressed hepatitis B virus core antigen derivatives for detection of anti-HBc antibodies in human sera.
    Li ZX; Hong GQ; Hu B; Liang MJ; Xu J; Li L
    Protein Expr Purif; 2007 Dec; 56(2):293-300. PubMed ID: 17897838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of low or negative titer of antibody to hepatitis B core antigen during the course of chronic hepatitis B virus infection in adolescents.
    Matsuura K; Tobe K; Iwasaki Y; Ikeda H; Takahashi K; Tsuji T
    Gastroenterol Jpn; 1993 Feb; 28(1):25-33. PubMed ID: 8440421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of enzyme immunoassay with radioimmunoassay for the detection of antibody to hepatitis B core antigen as the only marker of hepatitis B infection in a population with a high prevalence of hepatitis B.
    Parkinson AJ; McMahon BJ; Hall D; Ritter D; Fitzgerald MA
    J Med Virol; 1990 Apr; 30(4):253-7. PubMed ID: 2196336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
    Schödel F; Peterson D; Milich D
    Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A sero-epidemiological cross-sectional study of hepatitis B virus in Zimbabwe.
    Tswana S; Chetsanga C; Nyström L; Moyo S; Nzara M; Chieza L
    S Afr Med J; 1996 Jan; 86(1):72-5. PubMed ID: 8685787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease.
    Yuan Q; Song LW; Cavallone D; Moriconi F; Cherubini B; Colombatto P; Oliveri F; Coco BA; Ricco G; Bonino F; Shih JW; Xia NS; Brunetto MR
    PLoS One; 2015; 10(6):e0130209. PubMed ID: 26115521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity.
    Günther S; Paulij W; Meisel H; Will H
    Virology; 1998 Apr; 244(1):146-60. PubMed ID: 9581787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks.
    Oluyinka OO; Tong HV; Bui Tien S; Fagbami AH; Adekanle O; Ojurongbe O; Bock CT; Kremsner PG; Velavan TP
    PLoS One; 2015; 10(7):e0131912. PubMed ID: 26148052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.